Zevra Therapeutics (ZVRA) Interest Paid (2014 - 2026)
Zevra Therapeutics' Interest Paid was $1.37 million in Q1 2026, up 4.9% from $1.31 million a year earlier and up 2.5% from the prior quarter.
Powered by 
Analysis
Zevra Therapeutics (ZVRA) Interest Paid (2014 - 2026) Analysis & Trends
For FY2025, Interest Paid at Zevra Therapeutics came in at $5.33 million, up 1.3% from FY2024.
- Interest Paid shows a five-year compound annual growth rate of 132.8% (FY2020 to FY2025).
- In earlier years, Interest Paid was $5.26 million in FY2024, $456,000 in FY2023 (+42.1%), $321,000 in FY2022 (+47.2%) and $218,000 in FY2021 (+179.5%).
- The Q1 2026 figure marks the highest quarterly Interest Paid since Q4 2024.
- Compared with a year earlier, Interest Paid was higher in four of the last seven quarters, with growth averaging 342.4%.
- The best year-over-year quarter for Interest Paid over five years was Q2 2024 (growth of 933.7%); the worst was Q1 2022 (a decline of 97.5%).
- Per Business Quant data, ZVRA's Interest Paid in the three quarters before Q1 2026 was $1.34 million (Q4 2025), $1.37 million (Q3 2025) and $1.32 million (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Paid (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | - |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -1.78 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | - |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 283.00 Mn |
| 10 | Zevra Therapeutics | 708.52 Mn | -100.24 Mn | 36.01 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 1.37 Mn |
| Dec 31, 2025 | 1.34 Mn |
| Sep 30, 2025 | 1.37 Mn |
| Jun 30, 2025 | 1.32 Mn |
| Mar 31, 2025 | 1.31 Mn |
| Dec 31, 2024 | 1.59 Mn |
| Sep 30, 2024 | 1.53 Mn |
| Jun 30, 2024 | 2.00 Mn |
| Mar 31, 2024 | 140,000.00 |
| Sep 30, 2023 | -366,000.00 |
| Jun 30, 2023 | -197,000.00 |
| Mar 31, 2023 | 68,000.00 |
| Dec 31, 2022 | 156,000.00 |
| Sep 30, 2022 | -124,000.00 |
| Jun 30, 2022 | -36,000.00 |
| Mar 31, 2022 | 5,000.00 |
| Sep 30, 2021 | 6,000.00 |
| Jun 30, 2021 | 8,000.00 |
| Mar 31, 2021 | 199,000.00 |
| Sep 30, 2020 | 6,000.00 |
API Access
Zevra Therapeutics Interest Paid API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-paid&ticker=ZVRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-paid", "ticker": "ZVRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-paid&ticker=ZVRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();